secwatch.observer — SEC 8-K summary ====================================== Issuer: LeonaBio, Inc. (LONA) CIK: 0001620463 Form: 8-K Filed at: 2026-06-23T20:05:16+00:00 Accession: 0001193125-26-279425 Event type: other_material Sentiment: neutral Materiality: 0.15 Item codes: 5.07 LLM model: deepseek-v4-flash:cloud@v2 LeonaBio stockholders elect three Class III directors, ratify EY as auditor at 2026 annual meeting -------------------------------------------------------------------------------- - Kelly A. Romano, James A. Johnson, and Natalie Holles elected as Class III directors for three-year terms. - Ratification of Ernst & Young LLP as independent auditor for FY 2026 approved with 7,824,681 for, 10,708 against. - Advisory vote on executive compensation approved: 5,310,614 for, 24,139 against, 18,280 abstain. - Advisory vote favored every 3 years for future say-on-pay frequency (3,052,542 votes for 3 years vs 2,288,358 for 1 year). Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1620463/000119312526279425/0001193125-26-279425-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1620463/000119312526279425/lona-20260622.htm HTML page: https://secwatch.observer/filing/0001193125-26-279425 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer